Petteway Stephen R Jr 4
4 · Talecris Biotherapeutics Holdings Corp. · Filed Dec 2, 2010
Insider Transaction Report
Form 4
Petteway Stephen R Jr
Executive VP, R&D
Transactions
- Exercise/Conversion
Common Stock
2010-12-01$1.39/sh+20,000$27,800→ 75,198 total - Sale
Common Stock
2010-12-01$21.50/sh−25,000$537,500→ 50,198 total - Exercise/Conversion
Options (right to buy)
2010-12-01$1.39/sh−20,000$27,800→ 289,040 totalExercise: $1.39From: 2006-04-01Exp: 2015-11-10→ Common Stock (20,000 underlying)
Footnotes (3)
- [F1]The transaction reported was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 24, 2010.
- [F2]The number of shares reported includes restricted share units representing the right to receive 9,210 shares of the Issuers common stock that will vest in three equal annual installments beginning April 1, 2011, as detailed in a restricted share unit award agreement by and between the Issuer and the Reporting Person, dated as of September 30, 2009.
- [F3]The option is fully vested and immediately exercisable.